Skip to Content

ZC 25 (Meloxicam 7.5 mg)

Pill imprint ZC 25 has been identified as Meloxicam 7.5 mg.

Meloxicam is used in the treatment of inflammatory conditions; osteoarthritis; fibromyalgia; rheumatoid arthritis; tendonitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Meloxicam 7.5 mg ZC 25  Front
Meloxicam 7.5 mg ZC 25  Back
Meloxicam 7.5 mg ZC 25
ZC 25
7.5 mg
6.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
N - Not a controlled drug
Zydus Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
lactose monohydrate
magnesium stearate
silicon dioxide
trisodium citrate dihydrate
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
10544-0362 Blenheim Pharmacal Inc (repackager)
49999-0868 Lake Erie Medical and Surgical Supply (repackager)
16590-0434 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.